Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - COST OF REVENUE
Cost of Revenue REGN - Regeneron Pharmaceuticals, Inc.
1.82 B
LAST VALUE
-13.69%
2 YEAR CAGR
33.14%
5 YEAR CAGR
27.87%
10 YEAR CAGR